Studies of expression and possible functional role of purinergic receptors in cell-mediated immunity: Experimental approaches, controls, and caveats

Drug Development Research

Volumn 45, Issue 3-4, 1998, Pages 229-244

  Smith, Patrick T ^a  

^a MSC 1892 ^*  (United States)

Author keywords

Adenosine; ATP; Purinergic receptors; T lymphocytes

Indexed keywords

ADENOSINE A2A RECEPTOR; PURINE P2 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PURINERGIC RECEPTOR STIMULATING AGENT;

ANIMAL CELL; CELLULAR IMMUNITY; CONFERENCE PAPER; IMMUNE DEFICIENCY; IMMUNOMODULATION; NONHUMAN; PROTEIN EXPRESSION; T LYMPHOCYTE;

EID: 0032461357     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199811/12)45:3/4<229::AID-DDR21>3.0.CO;2-Z     Document Type: Conference Paper

References (51)

1. Alberola-Ila J, Takaki S, Kemer JD, Perlmutter RM. 1997. Differential signaling by lymphocyte antigen receptors. Annu Rev Immunol 15:125-154.
2. Anderson G, Moore NC, O\ven JJ, Jenkinson EJ. 1996. Cellular interactions in thymocyte development. Annu Rev Immunol 14:73-99.
3. Antonysamy MA, Moticka EJ, Ramkumar V. 1995. Adenosine acts as an endogenous modulator of IL-2 dependent proliferation ofcytotoxic T-lymphocytes. J Immunol 155:2813-2821.
4. Apasov S, Koshiba M, Redegeld F, Sitkovsky M. 1995. Role of extracellular ATP and PI and P2 classes of purinergic receptors in T-cell development and cytotoxic T lymphocyte effector functions. Immunol Rev 146:5-19.
5. Apasov SG, Smith FT, Jelonek MT, Margulies DM, Sitkovsky MY 1996. Phosphorylation of extracellular domains of T-Iymphocyte surface proteins: constitutive serine and threonine phosphorylation of the T cell antigen cell antigen receptor ectodomains. J Hiol Chem 271:25677-25683.
6. Apasov SG, Koshiba M, Chused TM, Sitkovsky MV. 1997. Effects of extracellular ATP and adenosine on different thymocyte subsets: possible role of ATP-gated channels and G protein-coupled purinergic receptors. J Immunol 158:5095-5105.
7. ++ ionophores. Proc Natl Acad Sei USA 84:1364-1368.
8. Berridge MJ. 1997. Lymphocyte activation in health and disease. Crit Rev Immunol 17:155-178.
9. Bevan MJ. 1997. In thymic selection, peptide diversity gives and takes away. Immunity 7:175-178.
10. Blanchard DK, Wei S, Duan C, Pericle F, Diaz JI, Djeu JY. 1995. Role of extracellular adenosine triphosphate in the cytotoxic T-Iymphocyte-mediated lysis of antigen presenting cells. Blood 85:3173-3182.
11. Brake A, Wagenbach MJ, Julius D. 1994. New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature 371:519-524.
12. Chused TM, Apasov S, Sitkovsky MY 1996. Murine T lymphocytes modulate activity of an ATP-activated p2z-type purinoreceptor during differentiation. J Immunol 157:1371-1380.
13. Chvatchko Y, Valera S, Aubry JP, Renno T, Buell G, Bonnefoy JY. 1996. The involvement of an ATP-gated ion channel, P(2X1), in thymocyte apoptosis. Immunity 5:275-283.
14. Davis MM, Lyons DS, Altman JD, McHeyzer-Williams M, Hampl J, Boniface JJ, Chien Y. 1997. T cell receptor biochemistry, repertoire selection and general features of TCR and Ig structure. Ciba Found Symp 204:94-104.
15. DiVirgilio F, Pizzo P, Zanovello P, Bronte V, Collavo D. 1990. Extracellular ATP as a possible mediator of cell-mediated cytotoxicity. Immunol Today 11:274-277.
16. Ehrlich YH. 1996. Extracellular protein kinases. Science 271:278-279.
17. Ferrari D, Chiozzi P, Falzoni S, DalSusmo M, Melchiorri L, Baricordi OR, DiVirgilio E 1997a. Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J Immunol 159:1451-1458.
18. Ferrari D, Chiozzi P, Falzoni S, Hanau S, DiVirgilio E 1997b. Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin. J Exp Med 185:579-582.
19. Filippini A, Sitkovsky M V 1990. Alternative molecular mechanisms of T-cell receptor regulated effector functions of cytolytic T-lymphocytes. J Immunol Immunopharmacol X4:149.
20. Filippini A, Taffs RE, Agui T, Sitkovsky MY 1990a. Ecto-ATPase activity in cytolytic T-lymphocytes: protection from the cytolytic effects of extracellular ATE J Biol Chein 265:334-340.
21. Filippini A, Taffs RE, Sitkovsky MY 1990b. Extracellular ATP in Tlymphocyte activation: possible role in effector functions. Proc Natl Acad Sei USA 87:8267-8271.
22. Harden TK, Lazarowski ER, Boucher RC. 1997. Release, metabolism and interconversion of adenine and undine nucleotides: implications for G protein-coupled P2 receptor agonist selectivity. Trends Pharmacol Sei 18:43-46.
23. Henkart PA, Sitkovsky MY 1994. Cytotoxic lymphocytes: two ways to kill target cells. Curr Biol 4:923-925.
24. Hogquist KA, Bevan MJ. 1996. The nature of the peptide/MHC ligand involved in positive selection. Semin Immunol 8:63-68.
25. Huaug S, Koshiba M, Apasov S, Sitkovsky M. 1997. Role of A2a adenosine receptor-mediated signaling in inhibition of T cell activation and expansion. Blood 90:1600-1610.
26. Jacobson KA, von Lubitz DK, Daly JW, Fredholm BB. 1996. Adenosine receptor ligands: differences with acute versus chronic treatment. Trends Pharmacol Sei 17:108-113.
27. Kincaid R, Takayama H, Billingsley M, Sitkovsky M. 19S7. Differential expression of calmodulin-binding proteins in B-, T-lymphocytes and thymocytes. Nature 330:176-178.
28. Koshiba M, Apasov S, Sverdlov V, Chen P, Erb L, Turner JT, Weisman GA, Sitkovsky MV. 1997a. Transient up-regulation of P2Y2 nucleotide receptor mRNA expression is an immediate early gene response iii activated thymocytes. Proc NatI Acad Sei USA 94:831-836.
29. Koshiba M, Kojima H, Huang S, Apasov S, Sitkovsky MY 1997b. Memor of extracellular adenosine/A2a pnrinergic receptor-mediated signalling in murine T cells. J Biol Chcm 272:25881.
30. Ledent C, Yaugeois JM, Schiffmann SN, Pedrazzini T, El Yaconbi M, Vanderhaeghen JJ, Costentin J, Heath JK, Vassart G, Parmentier M. 1997. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor, nature 388:674-678.
31. Linden J. 1994. Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions. Trends Pharmacol Sei 15:298-306.
32. Malissen B, Malisscn M. 1996. Functions of TCR and pre-TCR subunits: lessons from gene ablation. Curr Opin Immunol 8:383-393.
33. Murgia M, Hanau S, Pizzo P, Rippa M, DiVirgilio F 1993. Oxidized ATP: an irreversible inhibitor of the macrophage purinergic-P2Z receptor. J Biol Chem 268:8199-8203.
34. Nagata S, Suda T. 1995. Fas and Fas ligand: 1 pr and gld mutations. Immunol Today 16:39-43.
35. Naik UP, Komecki E, Ehrlich YH. 1991. Phosphorylation and dephosphorylation of human platelet surface proteins by an ecto-protein kinase/phosphatase system. Biochim Biophys Acta 1092:256-264.
36. Olah ME, Stiles GL. 1995. Adenosine receptor subtypes: characterization and therapeutic regulation. Annu Rev Pharmacol Toxicol 35:581-606.
37. Owens GP, Halm WE, Cohen JJ. 1991. Identification of mRNAs associated with programmed cell death in immature thymocyles. Mol Cell Biol 11:4177-4188.
38. Qian D, Weiss A. 1997. T cell antigen receptor signal transduction. Curr Opin Cell Biol 9:205-212.
39. Redegeld FA, Filippini A, Trenn G, Sitkovsky MY 1993. Possible role of extracellular ATP in cell-cell interactions leading to CTL-mediated cytotoxicity. In: Sitkovsky MV, Henkart PA, editors. Cytotoxic cells: recognition, effector functions, generation, and methods. Boston-Basel-Berlin: Birkhauser. p 307-314.
40. Redegeld FA, Smith P, Apasov S, Sitkovsky MC. 1997. Phosphoryla-tion of T-lymphocyte plasma membrane-associated proteins by ectoprotein kinases: implications for a possible role for ectophorylation in T cell effector functions. Biochim Biophys Acta 1328:151-163.
41. Robey E, Fowlkes BJ. 1994. Selective events in T cell development. Annn Rev Immunol 12:675-705.
42. Rosin DL, Robeva AS, Woodard RL, Guyenet PC, Linden J. 1998. Immunoliistocheniical localization of adenosine A2A receptors in the rat central nervous system. J Neurosci (in press).
43. 2+ independent T cell mediated cytotoxicity. J Exp Med 177:195-200.
44. Sitkovsky MV, Henkart PA. 1996. Mechanisms of T-cell mediated cytotoxicity in vivo and in vitro. In: FerraraJ, BurakoffS, editors. Graft-versus-host disease, 2nd Ed. Boston-Basel-Berlin: Birkhauser. p 219-233.
45. Skubitz KM, Goueli SA. 1994. CD31 (PECAM-1), Cdw32 (FCyRII) and anti-HLA Class I monoclonal antibodies recognize phosphotyrosine-containing proteins on the surface of human neutrophils. J Immunol 152:5902-5911.
46. Surch CD, Sprent J. 1994. T-cell apoptosis detected in situ during positive and negative selection in thymus. Nature 372:100-103.
47. Svenningsson P, Nomikos GG, Ongini E, Fredholm BB. 1997. Antagonism of adenosine A2A receptors underlies the behavioral activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens. Neuroscience 79:753-764.
48. Takayama H, Sitkovsky MV. 1987. Antigen receptor-regulated exocytosis in cytotoxic T lymphocytes. J Exp Med 166:725-743.
49. Trenn G, Takayama H, Sitkovsky MV. 19S7. Antigen-receptor regulated exocytosis of cylolytic granules may not be required for target cell lysis by cytotoxic T lymphocytes. Nature 330:72-74.
50. Valera S, Hussy N, Evans RJ, Adami N, North RA, Surprenant A, Buell G. 1994. A new class of ligand-gated ion channels defined by p2x receptor for extracellular ATE Nature 371:516-519.
51. Weisman G, De BK, Freidberg I, Pritchard RS, Heppel LA. 1984. Cellular responses to external ATP which precede an increase in nucleotide permeability in transformed cells. J Cell Physiol 119:211-219.